These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30038351)

  • 21. Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors.
    Perez LE; Fernandez H; Ayala E; Beato F; Neuger A; Pidala J; Schell MJ; Anasetti C
    Bone Marrow Transplant; 2017 Apr; 52(4):627-629. PubMed ID: 27991896
    [No Abstract]   [Full Text] [Related]  

  • 22. Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan.
    Goto T; Tanaka T; Sawa M; Ueda Y; Ago H; Chiba S; Kanamori H; Nishikawa A; Nougawa M; Ohashi K; Okumura H; Tanimoto M; Fukuda T; Kawashima N; Kato T; Okada K; Nagafuji K; Okamoto SI; Atsuta Y; Hino M; Tanaka J; Miyamura K
    Int J Hematol; 2018 Feb; 107(2):211-221. PubMed ID: 29027623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital.
    Escobar K; Rojas P; Ernst D; Bertin P; Nervi B; Jara V; Garcia MJ; Ocqueteau M; Sarmiento M; Ramirez P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):176-9. PubMed ID: 25139214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin.
    Kothari A; Ngwube A; Hayashi R; Murray L; Davis J; Haut P; Loechelt BJ; Shenoy S
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1321-5. PubMed ID: 25840334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
    Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study.
    Parody R; López-Corral L; Lopez-Godino O; Martinez C; Martino R; Solano C; Barba P; Caballero D; García-Cadenas I; Piñana JL; Marquez-Malaver FJ; Vazquez L; Esquirol A; Boluda JC; Sanchez-Guijo F; Pérez-Simon JA
    Bone Marrow Transplant; 2016 Nov; 51(11):1524-1526. PubMed ID: 27295268
    [No Abstract]   [Full Text] [Related]  

  • 28. Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years.
    El-Jawahri A; Li S; Antin JH; Spitzer TR; Armand PA; Koreth J; Nikiforow S; Ballen KK; Ho VT; Alyea EP; Dey BR; McAfee SL; Glotzbecker BE; Soiffer RJ; Cutler CS; Chen YB
    Biol Blood Marrow Transplant; 2016 May; 22(5):910-8. PubMed ID: 26748160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.
    Gao L; Liu J; Zhang Y; Chen X; Gao L; Zhang C; Liu Y; Kong P; Zhong J; Sun A; Du X; Su Y; Li H; Liu H; Peng X; Zhang X
    Leuk Res; 2017 Jun; 57():27-36. PubMed ID: 28273549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.
    Sakellari I; Batsis I; Bousiou Z; Mallouri D; Constantinou V; Gavriilaki E; Smias C; Yannaki E; Kaloyannidis P; Papaioannou G; Stavroyianni N; Syrigou A; Sotiropoulos D; Fylaktou A; Tsompanakou A; Saloum R; Anagnostopoulos A
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):658-666. PubMed ID: 28716402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation.
    Kanda Y; Kobayashi T; Mori T; Tanaka M; Nakaseko C; Yokota A; Watanabe R; Kako S; Kakihana K; Kato J; Tanihara A; Doki N; Ashizawa M; Kimura SI; Kikuchi M; Kanamori H; Okamoto S;
    Bone Marrow Transplant; 2016 Jan; 51(1):103-9. PubMed ID: 26437063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
    Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
    Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation.
    Kharfan-Dabaja MA; Parody R; Perkins J; Lopez-Godino O; Lopez-Corral L; Vazquez L; Caballero D; Falantes J; Shapiro J; Ortí G; Barba P; Valcárcel D; Esquirol A; Martino R; Piñana JL; Solano C; Tsalatsanis A; Pidala J; Anasetti C; Perez-Simón JA
    Bone Marrow Transplant; 2017 Mar; 52(3):438-444. PubMed ID: 27819684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
    Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in HLA-haploidentical transplantations.
    Showel M; Fuchs EJ
    Best Pract Res Clin Haematol; 2015; 28(2-3):141-6. PubMed ID: 26590771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
    Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of tacrolimus/mycophenolate mofetil as acute graft-versus-host disease prophylaxis and the impact of subtherapeutic tacrolimus levels in children after matched sibling donor allogeneic hematopoietic cell transplantation.
    Offer K; Kolb M; Jin Z; Bhatia M; Kung AL; George D; Garvin JH; Robinson C; Sosna J; Karamehmet E; Satwani P
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):496-502. PubMed ID: 25536217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation.
    Watz E; Remberger M; Ringden O; Ljungman P; Sundin M; Mattsson J; Uhlin M
    Transfusion; 2015 Oct; 55(10):2339-50. PubMed ID: 25968813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning.
    Akahoshi Y; Kako S; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Nishida J; Kanda Y
    Hematology; 2015 Aug; 20(7):410-5. PubMed ID: 25437012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.